Medical Packaging Company Signs $200 Million Syringe Sales Agreement

Sharps Technology, Inc. (NASDAQ: STSS and STSSW), an innovative medical device and pharmaceutical packaging company known for its patented, best-in-class syringe products, has recently made significant strides in the healthcare industry. The company announced the signing of a 5-year, $200 million syringe Sales Agreement (SA) with Nephron Pharmaceuticals. This agreement complements the Company's Asset Purchase Agreement (APA) to acquire the InjectEZ specialty syringe manufacturing assets in West Columbia, South Carolina. This strategic move aims to bolster Sharps' position in the specialized copolymer prefillable syringe (PFS) system industry within the United States. $Sharps Technology (STSS.US)$